Berberine protects diabetic nephropathy by suppressing epithelial-to-mesenchymal transition involving the inactivation of the NLRP3 inflammasome

Accumulating evidence has implicated that berberine (BBR) has a beneficial effect on diabetic kidney disease (DKD), but its mechanism is not clear. The aim of this study was to assess whether berberine could alleviate tubulointerstitial fibrosis and attenuate epithelial-to-mesenchymal transition (EM...

Olles dieđut

Bibliográfalaš dieđut

Váldodahkkit:	Zejun Ma, Lili Zhu, Shangshang Wang, Xin Guo, Bei Sun, Qilong Wang, Liming Chen
Materiálatiipa:	Artigo
Giella:	Inglês
Almmustuhtton:	Taylor & Francis Group 2022-12-01
Ráidu:	Renal Failure
Fáttát:	Diabetic kidney disease renal tubulointerstitial fibrosis epithelial-to-mesenchymal transition NLRP3 inflammasome berberine
Liŋkkat:	https://www.tandfonline.com/doi/10.1080/0886022X.2022.2079525
Fáddágilkorat:	Lasit fáddágilkoriid Eai fáddágilkorat, Lasit vuosttaš fáddágilkora!